1. Home
  2. Labeler Index
  3. Genentech, Inc.
  4. 50242-145
  5. NDC Package Code: 50242-145-01 Perjeta

NDC Package 50242-145-01 Perjeta

Pertuzumab Injection, Solution, Concentrate Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50242-145-01
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 14 mL in 1 VIAL, SINGLE-USE
Product Code:
50242-145
Proprietary Name:
Perjeta
Non-Proprietary Name:
Pertuzumab
Substance Name:
Pertuzumab
Usage Information:
Pertuzumab is used to treat certain types of breast cancer. It is also used to treat early stage breast cancer in patients who will be having surgery to remove the cancer. The types of cancers pertuzumab is used to treat are tumors that produce more than the normal amount of a certain substance called HER2 protein. This medication is called a monoclonal antibody. It works by attaching to the HER2 cancer cells and blocking them from dividing and growing. It may also destroy the cancer cells or signal the body (immune system) to destroy the cancer cells.
11-Digit NDC Billing Format:
50242014501
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1298948 - pertuzumab 420 MG in 14 ML Injection
  • RxCUI: 1298948 - 14 ML pertuzumab 30 MG/ML Injection
  • RxCUI: 1298948 - pertuzumab 420 MG per 14 ML Injection
  • RxCUI: 1298953 - Perjeta 420 MG in 14 ML Injection
  • RxCUI: 1298953 - 14 ML pertuzumab 30 MG/ML Injection [Perjeta]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Genentech, Inc.
    Dosage Form:
    Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • PERTUZUMAB 30 mg/mL
    • Pharmacologic Class(es):
  • HER2/Neu/cerbB2 Antagonists - [MoA] (Mechanism of Action)
  • HER2/neu Receptor Antagonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    BLA125409
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    06-08-2012
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 50242-145-01 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    50242014501J9306Injection, pertuzumab, 1 mg1 MG141420420

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50242-145-01?

    The NDC Packaged Code 50242-145-01 is assigned to a package of 1 vial, single-use in 1 carton / 14 ml in 1 vial, single-use of Perjeta, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is injection, solution, concentrate and is administered via intravenous form.

    Is NDC 50242-145 included in the NDC Directory?

    Yes, Perjeta with product code 50242-145 is active and included in the NDC Directory. The product was first marketed by Genentech, Inc. on June 08, 2012 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 50242-145-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 50242-145-01?

    The 11-digit format is 50242014501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250242-145-015-4-250242-0145-01